Earnings
ADCT
29.33
+4.23%
1.19
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
439.19M
--
--
--
--
--
1.44M
--
--
--
8.15M
1.66M
450.45M
4.76M
--
47.91M
--
--
10.18M
--
397.00K
63.24M
513.69M
--
5.28M
0.00
--
--
--
--
--
12.06M
--
--
--
18.46M
40.44M
37.24M
--
--
--
100.51M
137.75M
178.19M
6.31M
981.06M
-652.11M
-4000.00
--
--
335.50M
335.50M
513.69M
FY 2019-12-31
115.55M
--
--
0.00
--
--
1.10M
--
--
--
4.21M
1.74M
122.61M
6.27M
--
--
--
--
8.43M
--
368.00K
15.08M
137.68M
--
3.33M
0.00
--
--
--
--
--
5.73M
--
--
--
9.76M
19.94M
3.90M
--
--
--
2.68M
6.58M
26.53M
4.36M
549.92M
-443.10M
-100.00K
--
--
111.16M
111.16M
137.68M
FY 2018-12-31
138.81M
--
--
192.00K
--
--
1.52M
--
--
--
1.38M
180.00K
142.08M
1.54M
--
--
--
--
6.67M
--
264.00K
8.48M
150.56M
--
6.75M
0.00
--
--
--
--
--
4.94M
--
--
--
10.66M
22.35M
0.00
--
--
--
1.96M
1.96M
24.32M
401.00K
452.27M
-326.38M
--
--
--
126.24M
126.24M
150.56M
FY 2017-12-31
262.75M
--
--
1.09M
--
--
840.00K
--
--
--
394.00K
101.00K
265.17M
1.14M
--
--
--
--
5.40M
--
232.00K
6.78M
271.95M
--
7.62M
0.00
--
--
--
--
--
4.39M
--
--
--
8.54M
20.55M
0.00
--
--
--
2.24M
2.24M
22.78M
397.00K
452.30M
-203.56M
--
--
--
249.17M
249.17M
271.95M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out ADCT latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze ADC Therapeutics recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.